Author: Hsu, Shih-Hsien; Yeh, Ming-Lun; Wang, Shen-Nien
Title: New Insights in Recurrent HCV Infection after Liver Transplantation Document date: 2013_4_23
ID: 0hbeso65_43
Snippet: Interfering with HCV entry into the hepatocytes holds great promises for the development of novel drugs. Several potential targets are suggested: (1) blocking virus-target cell interaction during attachment and binding; (2) interfering with postbinding events and (3) interfering with viral fusion. Various modalities may be adopted as HCV entry inhibitors: neutralizing antibodies for HCV envelope glycoproteins, blocking antibodies specific for hos.....
Document: Interfering with HCV entry into the hepatocytes holds great promises for the development of novel drugs. Several potential targets are suggested: (1) blocking virus-target cell interaction during attachment and binding; (2) interfering with postbinding events and (3) interfering with viral fusion. Various modalities may be adopted as HCV entry inhibitors: neutralizing antibodies for HCV envelope glycoproteins, blocking antibodies specific for host factors, and small molecular compounds against host factors or viral proteins.
Search related documents:
Co phrase search for related documents- binding attachment and entry inhibitor: 1, 2
- binding attachment and envelope glycoprotein: 1
- binding attachment and HCV entry: 1
- binding attachment and host factor: 1, 2, 3
- binding attachment and molecular compound: 1
- binding attachment and neutralize antibody: 1
- binding attachment and novel drug: 1, 2
- binding attachment and novel drug development: 1
- cell interaction and entry inhibitor: 1, 2, 3, 4
- cell interaction and envelope glycoprotein: 1, 2, 3, 4, 5
- cell interaction and great promise: 1
- cell interaction and HCV entry: 1, 2
- cell interaction and host factor: 1, 2, 3, 4, 5, 6, 7
- cell interaction and molecular compound: 1
- cell interaction and neutralize antibody: 1
- cell interaction and novel drug: 1, 2, 3, 4
- cell interaction and novel drug development: 1, 2
- entry inhibitor and envelope glycoprotein: 1, 2, 3
- entry inhibitor and HCV entry: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date